Cryopreservation of Ovarian Tissue for Potential In Vitro Maturation or Autologous Transplantation
The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.
• Females 0-45 years of age who are premenopausal
• Treatment plan that will likely result in premature menopause or premature ovarian failure
• This includes patients receiving:
• Cancer treatment with abdominal pelvic irradiation and/or high dose chemotherapy
• Surgery that requires removal of ovaries for medical condition or disease, e.g. Prophylactic oophorectomy in BRCA patients
• Patient is unable or unwilling to pursue fertility preservation by freezing oocytes or embryos.
• Previous treatment for cancer is acceptable if patient still has ovarian function
• Patient is medically stable enough to undergo surgery (cleared for anesthesia)